2022's commercial loan production was split in two halves. Production was going gangbusters till about mid-year when corporate bonds and interest rates went up and haltered production for banks and life companies alike. Lack of transactions made it difficult to value multi-family projects and seller's were still seeking CAP rates from 6-months prior.
2023 looks more optimistic for most life company lenders. Some have almost completed their 2023 production goals. Some lenders are only wanting to place loans withing the CM-1 parameters, but aren't having too much success so far. The lenders who are making loans and actively winning deals are placing loans within the CM-2 parameters. Here are some additional bullet points from our conference meetings:
CM Ratings
· CM-1: Debt coverage of at least 1.50x on 25-yr amort (75% or lower LTV) on Retail, Office, Industrial, Multi. Debt coverage of at least 1.85x on 25-yr amort (60% or lower LTV) on Hotel
· CM-2: Debt coverage of 1.15x – 1.50x on 25-yr amort (1.45x – 1.85x on Hotel)
o CM-1 loans typically priced 30-50 bps lower than CM-2 (regulators require significantly higher internal reserves from lender for CM-2 loans)
o Some lenders want a CM-1 rating on all their loans, but they aren’t getting as many deals done with increased rates impacting DCR. Those that are doing more deals are within the CM-2 rating standards. Very likely that the lenders who prefer CM-1 loans will reduce that standard mid-year to get their money out.
Spreads are all over the place: 140 – 270Many borrowers opting for 5-7 year loans
Office: “Not closing the door on office, but it needs to be a good story AND a good sponsor.”
i. Occupancy important, but utilization also critical
ii. Medical office is still a good asset
iii. Nobody very familiar yet with new Regus license agreement concept
Hotel: very difficult environment – CMBS likely right now.Retail is back! Desire for more Multi and Industrial remains, though not as heavy as prior years.